| Product Code: ETC10689277 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Oncology Companion Diagnostics Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Argentina Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Argentina Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Argentina Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Argentina Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Argentina Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Argentina Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Argentina |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in companion diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High cost associated with companion diagnostic tests |
4.3.3 Limited access to advanced healthcare facilities in certain regions of Argentina |
5 Argentina Oncology Companion Diagnostics Market Trends |
6 Argentina Oncology Companion Diagnostics Market, By Types |
6.1 Argentina Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Argentina Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Argentina Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Argentina Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Argentina Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Argentina Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Argentina Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Argentina Oncology Companion Diagnostics Market Imports from Major Countries |
8 Argentina Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Argentina |
8.2 Adoption rate of personalized medicine in oncology |
8.3 Investment in research and development for companion diagnostics |
8.4 Number of partnerships between pharmaceutical companies and diagnostic companies for companion diagnostics |
8.5 Percentage of oncology patients in Argentina receiving companion diagnostic testing. |
9 Argentina Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Argentina Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Argentina Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Argentina Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Argentina Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Argentina Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Argentina Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Argentina Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here